515 related articles for article (PubMed ID: 30853582)
21. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
[TBL] [Abstract][Full Text] [Related]
22. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
Luo GR; Le WD
Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
[TBL] [Abstract][Full Text] [Related]
23. [Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].
Nagai Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):913-6. PubMed ID: 20030247
[TBL] [Abstract][Full Text] [Related]
24. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
Muchowski PJ
Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
[TBL] [Abstract][Full Text] [Related]
25. Neurodegenerative disorders: dysregulation of a carefully maintained balance?
Swart C; Haylett W; Kinnear C; Johnson G; Bardien S; Loos B
Exp Gerontol; 2014 Oct; 58():279-91. PubMed ID: 25219768
[TBL] [Abstract][Full Text] [Related]
26. Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging.
Hinault MP; Ben-Zvi A; Goloubinoff P
J Mol Neurosci; 2006; 30(3):249-65. PubMed ID: 17401151
[TBL] [Abstract][Full Text] [Related]
27. Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides.
Truttmann MC; Pincus D; Ploegh HL
Proc Natl Acad Sci U S A; 2018 May; 115(22):E5008-E5017. PubMed ID: 29760078
[TBL] [Abstract][Full Text] [Related]
28. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies.
Ebrahimi-Fakhari D; Saidi LJ; Wahlster L
Acta Neuropathol Commun; 2013 Dec; 1(1):79. PubMed ID: 24314025
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
Hervás R; Oroz J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
[TBL] [Abstract][Full Text] [Related]
30. Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
Blumenstock S; Schulz-Trieglaff EK; Voelkl K; Bolender AL; Lapios P; Lindner J; Hipp MS; Hartl FU; Klein R; Dudanova I
EMBO J; 2021 Oct; 40(19):e107260. PubMed ID: 34410010
[TBL] [Abstract][Full Text] [Related]
31. Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.
Wang L; Bergkvist L; Kumar R; Winblad B; Pavlov PF
Cells; 2021 Sep; 10(10):. PubMed ID: 34685574
[TBL] [Abstract][Full Text] [Related]
32. Heat shock proteins as potential targets for protective strategies in neurodegeneration.
Kampinga HH; Bergink S
Lancet Neurol; 2016 Jun; 15(7):748-759. PubMed ID: 27106072
[TBL] [Abstract][Full Text] [Related]
33. The therapeutic potential of chemical chaperones in protein folding diseases.
Cortez L; Sim V
Prion; 2014; 8(2):197-202. PubMed ID: 24818993
[TBL] [Abstract][Full Text] [Related]
34. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
35. The heat shock response in neurons and astroglia and its role in neurodegenerative diseases.
San Gil R; Ooi L; Yerbury JJ; Ecroyd H
Mol Neurodegener; 2017 Sep; 12(1):65. PubMed ID: 28923065
[TBL] [Abstract][Full Text] [Related]
36. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
[TBL] [Abstract][Full Text] [Related]
37. Heat shock proteins and neuroprotection.
Trivedi S
Recent Pat DNA Gene Seq; 2007; 1(2):134-7. PubMed ID: 19075927
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
40. The role of chaperones in Parkinson's disease and prion diseases.
Winklhofer KF; Tatzelt J
Handb Exp Pharmacol; 2006; (172):221-58. PubMed ID: 16610362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
